# Catherine M. Tangen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/catherine-m-tangen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 64,801 |
| Field | Prostate Cancer Treatment and Research |
| h-index | 81 |
| i10-index | 230 |
| Last Known Institution | Fred Hutch Cancer Center |
| OpenAlex ID | https://openalex.org/A5026563364 |
| ORCID iD | https://orcid.org/0000-0001-8825-8660 |
| Works | 471 |

## Researcher papers

- [Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer](https://scholariq.org/papers/docetaxel-and-estramustine-compared-with-mitoxantrone-and-prednisone-for/)
- [Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci](https://scholariq.org/papers/association-analyses-of-more-than-140-000-men-identify-63-new-prostate-cancer/)
- [Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis](https://scholariq.org/papers/physical-activity-and-risks-of-breast-and-colorectal-cancer-a-mendelian/)
- [Intermittent versus Continuous Androgen Deprivation in Prostate Cancer](https://scholariq.org/papers/intermittent-versus-continuous-androgen-deprivation-in-prostate-cancer/)
- [Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction](https://scholariq.org/papers/trans-ancestry-genome-wide-association-meta-analysis-of-prostate-cancer/)
- [Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Resistant Prostate Cancer](https://scholariq.org/papers/circulating-tumor-cell-counts-are-prognostic-of-overall-survival-in-swog-s0421-a/)
- [Evaluation of Prostate-Specific Antigen Declines for Surrogacy in Patients Treated on SWOG 99-16](https://scholariq.org/papers/evaluation-of-prostate-specific-antigen-declines-for-surrogacy-in-patients/)
- [Cumulative Burden of Colorectal Cancer–Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer](https://scholariq.org/papers/cumulative-burden-of-colorectal-cancer-associated-genetic-variants-is-more/)
- [Meta‐analysis of 16 studies of the association of alcohol with colorectal cancer](https://scholariq.org/papers/meta-analysis-of-16-studies-of-the-association-of-alcohol-with-colorectal-cancer/)

## Researcher topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Genetic Associations and Epidemiology](https://scholariq.org/topics/genetic-associations-and-epidemiology/)
- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Statistical Methods in Clinical Trials](https://scholariq.org/topics/statistical-methods-in-clinical-trials/)

## Researcher university

- [Fred Hutch Cancer Center](https://scholariq.org/institutions/fred-hutch-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.